- Home
- FWONA vs TEVA Comparison
FWONA vs TEVA Comparison
Compare FWONA & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FWONA
- TEVA
- Stock Information
- Founded
- FWONA 1950
- TEVA 1901
- Country
- FWONA United States
- TEVA Israel
- Employees
- FWONA N/A
- TEVA N/A
- Industry
- FWONA Broadcasting
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- FWONA Industrials
- TEVA Health Care
- Exchange
- FWONA Nasdaq
- TEVA Nasdaq
- Market Cap
- FWONA 20.3B
- TEVA 18.4B
- IPO Year
- FWONA N/A
- TEVA N/A
- Fundamental
- Price
- FWONA $86.73
- TEVA $17.99
- Analyst Decision
- FWONA Strong Buy
- TEVA Strong Buy
- Analyst Count
- FWONA 1
- TEVA 6
- Target Price
- FWONA $81.00
- TEVA $24.33
- AVG Volume (30 Days)
- FWONA 89.3K
- TEVA 12.8M
- Earning Date
- FWONA 05-07-2025
- TEVA 05-07-2025
- Dividend Yield
- FWONA N/A
- TEVA N/A
- EPS Growth
- FWONA N/A
- TEVA N/A
- EPS
- FWONA N/A
- TEVA N/A
- Revenue
- FWONA $3,653,000,000.00
- TEVA $16,616,000,000.00
- Revenue This Year
- FWONA $14.34
- TEVA $6.30
- Revenue Next Year
- FWONA $6.85
- TEVA N/A
- P/E Ratio
- FWONA N/A
- TEVA N/A
- Revenue Growth
- FWONA 13.38
- TEVA 3.82
- 52 Week Low
- FWONA $61.27
- TEVA $12.47
- 52 Week High
- FWONA $95.33
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- FWONA 67.61
- TEVA 73.25
- Support Level
- FWONA $82.07
- TEVA $14.17
- Resistance Level
- FWONA $87.60
- TEVA $18.30
- Average True Range (ATR)
- FWONA 2.02
- TEVA 0.58
- MACD
- FWONA 1.03
- TEVA 0.44
- Stochastic Oscillator
- FWONA 93.00
- TEVA 93.49
About FWONA Liberty Media Corporation Series A Liberty Formula One
Liberty Media Corp along with its subsidiaries is engaged in the media and entertainment industries in North America and the United Kingdom. The company owns interests in a high-quality portfolio of assets across the media, entertainment and sports industries. The company derives its maximum revenue from United Kingdom.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.